Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. [electronic resource]
Producer: 20050518Description: 325-34 p. digitalISSN:- 0277-0008
- Adult
- Antineoplastic Agents -- economics
- Benzamides
- Bone Marrow Transplantation -- economics
- Chronic Disease
- Cost-Benefit Analysis
- Decision Support Techniques
- Health Care Costs
- Humans
- Imatinib Mesylate
- Insurance, Health, Reimbursement -- economics
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- economics
- Male
- Markov Chains
- Monte Carlo Method
- Piperazines -- economics
- Pyrimidines -- economics
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.